Rollins, Inc.
Rollins, Inc. is a North American pest control company serving residential and commercial clients. Operating globally through its wholly owned subsidiaries, Orkin, Inc., PCO Services, HomeTeam Pest Defense, Western Pest Services, Industrial Fumigant Company, TruTech, Critter Control, Crane, Waltham, OPC Services, PermaTreat, Northwest Exterminating, McCall Service and Clark Pest Control, as well UK subsidiaries Integrated Pest Management Limited, Safeguard Pest Control, NBC Environment, Europest Environmental Services, Guardian Pest Control, Ames, Kestrel and Beaver Pest Control, with Australian subsidiaries Allpest, Scientific Pest Control, Murray Pest Control and Statewide Pest Control, and Singapore subsidiary Aardwolf Pestkare, the company provides pest control services and protection against termite damage, rodents and insects to over 2.8 million customers in the US, Canada, United Kingdom, Mexico, Central America, the Caribbean, the Middle East and Asia from over 800 locations.
If you'd bought from year…
Same habit, different start year. Each row shows what a constant habit's worth of ROL would be worth today, had you started buying at that point in the asset's history.
| Started | $6/day$6/day coffee | $42/wk$42/week coffee |
|---|---|---|
| Year 1 (1980) — listing | $5,434,228 77.8× | $7,871,003 77.7× |
| Year 6 (1985) | $2,959,514 47.3× | $4,280,641 47.2× |
| Year 11 (1990) | $1,759,923 32.0× | $2,551,548 32.0× |
| Year 16 (1995) | $1,157,856 24.4× | $1,680,594 24.4× |
| Year 21 (2000) | $676,611 17.0× | $985,128 17.0× |
| Year 26 (2005) | $273,532 8.5× | $397,553 8.5× |
| Year 31 (2010) | $110,474 4.5× | $160,617 4.5× |
| Year 36 (2015) | $38,250 2.2× | $55,596 2.2× |
| Year 41 (2020) | $12,639 1.3× | $18,365 1.3× |
| Year 46 (2025) | $1,883 0.9× | $2,739 0.9× |
Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.
Headquarters
Atlanta, Georgia, United States
Popular scenarios with ROL
For illustration only — not investment advice. Past performance is not indicative of future results.